DBVT compared with FTH: revenue, margins and what each company keeps, and the suppliers and customers both name

DBVTDBV Technologies S.A.

Mkt capRevenueRevenue

FTHFaeth Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

DBVTDBV Technologies S.A.

FTHFaeth Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DBVT1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±43.1%▼−3.38%×0.08

FTH1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.73%—

= impliedDBVT realized, solidFTH realized, hatchedOne scale, both sides: full bar = 44%× = |realized| ÷ impliedSource: market data

DBVTDBV Technologies S.A.

9.45▼−8.13%· post 9.45

Mkt cap$596.7MRevenue$2MQ3 FY26Revenue$6MFY25

FTHFaeth Therapeutics, Inc.

18.21▼−2.89%· post 18.32

ClosedOct 30 '26

Mkt cap$483.0MRevenue—Revenue—

Compare

ClosedOct 30 '26

DBVTDBV Technologies S.A.

FTHFaeth Therapeutics, Inc.

9.45▼−8.13%post 9.45

Price

18.21▼−2.89%post 18.32

$596.7M

Mkt cap

$483.0M

Q3 FY26$2M

Revenue

—

FY25$6M

Revenue

—

DBVT9.45▼−8.13%vsFTH18.21▼−2.89%ClosedOct 30 '26